Cardiovascular health and sleep disturbances in two population-based cohort studies
Autor: | Pedro Marques-Vidal, Pierre Boutouyrie, José Haba-Rubio, Quentin Lisan, Marie-Cécile Perier, Thomas T. van Sloten, Nicolas Danchin, Jean-Philippe Empana, Raphael Heinzer, Nadine Häusler, Catherine Guibout, Xavier Jouven, Frédérique Thomas |
---|---|
Přispěvatelé: | RS: Carim - V01 Vascular complications of diabetes and metabolic syndrome, RS: CARIM - R3.01 - Vascular complications of diabetes and the metabolic syndrome, MUMC+: MA Med Staf Artsass Interne Geneeskunde (9) |
Rok vydání: | 2019 |
Předmět: |
Blood Glucose
Male Health Status Health Behavior Excessive daytime sleepiness Disease Polysomnography 030204 cardiovascular system & hematology Severity of Illness Index cardiac risk factors and prevention DISEASE Body Mass Index Cohort Studies 0302 clinical medicine Epidemiology Insomnia 030212 general & internal medicine Prospective cohort study GENERAL-POPULATION medicine.diagnostic_test Smoking ASSOCIATION Middle Aged PREVALENCE Cholesterol Aged Blood Glucose/analysis Cholesterol/blood Diet Exercise Female France/epidemiology Humans Hypertension/epidemiology Sleep Wake Disorders/epidemiology Smoking/epidemiology Switzerland/epidemiology epidemiology Hypertension France medicine.symptom Cardiology and Cardiovascular Medicine Switzerland Sleep Wake Disorders medicine.medical_specialty Odds EVENTS 03 medical and health sciences AGE Internal medicine mental disorders medicine business.industry MORTALITY INSOMNIA Relative risk EXCESSIVE DAYTIME SLEEPINESS business |
Zdroj: | Heart, 105(19), 1500-1506. BMJ Publishing Group Heart, vol. 105, no. 19, pp. 1500-1506 |
ISSN: | 1468-201X 1355-6037 |
DOI: | 10.1136/heartjnl-2018-314485 |
Popis: | ObjectiveWe aimed to investigate the association between cardiovascular health (CVH), as defined by the American Heart Association, and several sleep disturbances.MethodsTwo community-based cohorts, the Paris Prospective Study 3 (PPS3, France, n=6441) and the CoLaus study (Switzerland, n=2989) were analysed. CVH includes 7 metrics which all can be classified as poor, intermediate and ideal. Global CVH score was categorised into poor (0–2 ideal metrics), intermediate (3–4 ideal metrics) and ideal (≥5 ideal metrics). Associations between global CVH and self-reported sleep disturbances (proxy of sleep-disordered breathing [SDB], excessive daytime sleepiness, insomnia symptoms and short/long sleep duration) and SDB severity measured by polysomnography (PSG) were investigated. Adjusted OR/relative risk ratio (RRR) and 95% CIs were estimated. Subjects with previous cardiovascular disease were excluded.ResultsCompared with poor CVH, subjects with intermediate and ideal global CVH had lower odds of self-reported SDB in both cohorts (ORs 0.55; 95% CI 0.44 to 0.68 and 0.35; 95% CI 0.22 to 0.53, respectively) and had lower SDB severity measured by PSG (RRR 0.07; 95% CI 0.02 to 0.20) in CoLaus. Subjects with intermediate and ideal global CVH had lower odds of excessive daytime sleepiness in PPS3 (ORs 0.82; 0.72 to 0.95 and 0.80; 0.82 to 1.02, respectively). No consistent associations were found between CVH and sleep duration or insomnia symptoms.ConclusionsHigher levels of CVH are associated with lower odds of SDB and excessive daytime sleepiness. However, causal interpretation cannot be made and associations might be bidirectional. |
Databáze: | OpenAIRE |
Externí odkaz: |